1,720,990 research outputs found
supplementary_table_1 – Supplemental material for Time course of lymphocyte repopulation after dimethyl fumarate-induced grade 3 lymphopenia: contribution of patient age
No full textSupplemental material, supplementary_table_1 for Time course of lymphocyte repopulation after dimethyl fumarate-induced grade 3 lymphopenia: contribution of patient age by Myriam Briner, Maud Bagnoud, Andrei Miclea, Christoph Friedli, Lara Diem, Andrew Chan, Robert Hoepner and Anke Salmen in Therapeutic Advances in Neurological Disorders</p
supplementary_table_2 – Supplemental material for Time course of lymphocyte repopulation after dimethyl fumarate-induced grade 3 lymphopenia: contribution of patient age
No full textSupplemental material, supplementary_table_2 for Time course of lymphocyte repopulation after dimethyl fumarate-induced grade 3 lymphopenia: contribution of patient age by Myriam Briner, Maud Bagnoud, Andrei Miclea, Christoph Friedli, Lara Diem, Andrew Chan, Robert Hoepner and Anke Salmen in Therapeutic Advances in Neurological Disorders</p
sj-docx-1-tan-10.1177_17562864221129383 – Supplemental material for Multiple Sclerosis immunotherapies and COVID-19 mortality: an analysis of the FDA Adverse Event Reporting System
No full textSupplemental material, sj-docx-1-tan-10.1177_17562864221129383 for Multiple Sclerosis immunotherapies and COVID-19 mortality: an analysis of the FDA Adverse Event Reporting System by Maximilian Pistor, Robert Hoepner, Andreas G.F. Hoepner, Yanan Lin, Simon Jung, Claudio L. Bassetti, Andrew Chan and Anke Salmen in Therapeutic Advances in Neurological Disorders</p
Therapeutic_advances_CIS_Supplementary_table – Supplemental material for Prediction of conversion to multiple sclerosis using the 2017 McDonald and 2016 MAGNIMS criteria in patients with clinically isolated syndrome: a retrospective single-centre study
No full textSupplemental material, Therapeutic_advances_CIS_Supplementary_table for Prediction of conversion to multiple sclerosis using the 2017 McDonald and 2016 MAGNIMS criteria in patients with clinically isolated syndrome: a retrospective single-centre study by Andrei Miclea, Anke Salmen, Roland Wiest, Greta Zoehner, Franca Wagner, Andreas Hoepner, Lisa Schrewe, Maria Eleftheria Evangelopoulos, Nicole Kamber, Andrew Chan and Robert Hoepner in Therapeutic Advances in Neurological Disorders</p
Therapeutic_advances_CIS_Supplementary_text – Supplemental material for Prediction of conversion to multiple sclerosis using the 2017 McDonald and 2016 MAGNIMS criteria in patients with clinically isolated syndrome: a retrospective single-centre study
No full textSupplemental material, Therapeutic_advances_CIS_Supplementary_text for Prediction of conversion to multiple sclerosis using the 2017 McDonald and 2016 MAGNIMS criteria in patients with clinically isolated syndrome: a retrospective single-centre study by Andrei Miclea, Anke Salmen, Roland Wiest, Greta Zoehner, Franca Wagner, Andreas Hoepner, Lisa Schrewe, Maria Eleftheria Evangelopoulos, Nicole Kamber, Andrew Chan and Robert Hoepner in Therapeutic Advances in Neurological Disorders</p
sj-docx-1-tan-10.1177_17562864241237853 – Supplemental material for Sex differences in multiple sclerosis relapse presentation and outcome: a retrospective, monocentric study of 134 relapse events
No full textSupplemental material, sj-docx-1-tan-10.1177_17562864241237853 for Sex differences in multiple sclerosis relapse presentation and outcome: a retrospective, monocentric study of 134 relapse events by Pauline Thränhardt, Admirim Veselaj, Christoph Friedli, Franca Wagner, Stefanie Marti, Lara Diem, Helly Hammer, Piotr Radojewski, Roland Wiest, Andrew Chan, Robert Hoepner and Anke Salmen in Therapeutic Advances in Neurological Disorders</p
sj-pdf-1-cns-10.1177_11795735221102727 – Supplemental Material for Fatigue in Post-COVID-19 Syndrome: Clinical Phenomenology, Comorbidities and Association With Initial Course of COVID-19
No full textSupplemental Material, sj-pdf-1-cns-10.1177_11795735221102727 for Fatigue in Post-COVID-19 Syndrome: Clinical Phenomenology, Comorbidities and Association With Initial Course of COVID-19 by Lara Diem, LiviaFregolente-Gomes, Jan D. Warncke, Helly Hammer, Christoph Friedli, Nicole Kamber, Simon Jung, Sandra Bigi, Manuela Funke-Chambour, Andrew Chan, Claudio L. Bassetti, Anke Salmen and Robert Hoepner in Journal of Central Nervous System Disease</p
Correlation_coefficient – Supplemental material for Reduced serum immunoglobulin G concentrations in multiple sclerosis: prevalence and association with disease-modifying therapy and disease course
No full textSupplemental material, Correlation_coefficient for Reduced serum immunoglobulin G concentrations in multiple sclerosis: prevalence and association with disease-modifying therapy and disease course by Greta Zoehner, Andrei Miclea, Anke Salmen, Nicole Kamber, Lara Diem, Christoph Friedli, Maud Bagnoud, Farhad Ahmadi, Myriam Briner, Nazanin Sédille-Mostafaie, Constantinos Kilidireas, Leonidas Stefanis, Andrew Chan, Robert Hoepner and Maria Eleftheria Evangelopoulos in Therapeutic Advances in Neurological Disorders</p
Supplemental material for Factors associated with time from first-symptoms to diagnosis and treatment initiation of Multiple Sclerosis in Switzerland
No full textSupplemental Material for Factors associated with time from first-symptoms to diagnosis and treatment initiation of Multiple Sclerosis in Switzerland by Marco Kaufmann, Jens Kuhle, Milo A Puhan, Christian P Kamm, Andrew Chan, Anke Salmen, Jürg Kesselring, Pasquale Calabrese, Claudio Gobbi, Caroline Pot, Nina Steinemann, Rodgers Stephanie Viktor von Wyl and for the Swiss Multiple Sclerosis Registry (SMSR) in Multiple Sclerosis Journal—Experimental, Translational and Clinical</p
MSJ823955_supplemental_material – Supplemental material for How do patients enter the healthcare system after the first onset of multiple sclerosis symptoms? The influence of setting and physician specialty on speed of diagnosis
No full textSupplemental material, MSJ823955_supplemental_material for How do patients enter the healthcare system after the first onset of multiple sclerosis symptoms? The influence of setting and physician specialty on speed of diagnosis by Laura Barin, Christian P Kamm, Anke Salmen, Holger Dressel, Pasquale Calabrese, Caroline Pot, Sven Schippling, Claudio Gobbi, Stefanie Müller, Andrew Chan, Stephanie Rodgers, Marco Kaufmann, Vladeta Ajdacic-Gross, Nina Steinemann, Jürg Kesselring, Milo A Puhan and Viktor von Wyl in Multiple Sclerosis Journal</p
- …
